» Articles » PMID: 35289751

A Lifestyle Intervention to Delay Early Chronic Kidney Disease in African Americans With Diabetic Kidney Disease: Pre-Post Pilot Study

Overview
Journal JMIR Form Res
Publisher JMIR Publications
Date 2022 Mar 15
PMID 35289751
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Behavioral factors, such as lifestyle, have been shown to explain approximately 24% of the excess risk of chronic kidney disease (CKD) among African Americans. However, there are limited intervention studies culturally tailored to African Americans with type 2 diabetes mellitus and CKD.

Objective: The main objective of this study was to examine the feasibility and preliminary efficacy of a culturally tailored lifestyle intervention among African Americans with type 2 diabetes mellitus and CKD.

Methods: A pre-post design was used to test the feasibility of a lifestyle intervention in 30 African American adults recruited from the Medical University of South Carolina between January 2017 and February 2017. A research nurse delivered the manualized study intervention weekly for 6 weeks. Clinical outcomes (hemoglobin A, blood pressure, and estimated glomerular filtration rate [eGFR]) were measured at baseline and postintervention. Disease knowledge, self-care, and behavior outcomes were also measured using validated structured questionnaires at baseline and postintervention. Descriptive statistics and effect sizes were calculated to determine clinically important changes from baseline.

Results: Significant pre-post mean differences and decreases were observed for hemoglobin A (mean 0.75%, 95% CI 0.16-1.34; P=.01), total cholesterol (mean 16.38 mg/dL, 95% CI 5.82-26.94; P=.004), low-density lipoprotein (mean 13.73 mg/dL, 95% CI 3.91-23.54; P=.008), and eGFR (mean 6.73 mL/min/1.73m, 95% CI 0.97-12.48; P=.02). Significant pre-post mean differences and increases were observed for CKD self-efficacy (mean -11.15, 95% CI -21.55 to -0.75; P=.03), CKD knowledge (mean -2.62, 95% CI -3.98 to -1.25; P<.001), exercise behavior (mean -1.21, 95% CI -1.96 to -0.46; P=.003), and blood sugar testing (mean -2.15, 95% CI -3.47 to -0.83; P=.003).

Conclusions: This study provides preliminary data for a large-scale appropriately powered randomized controlled trial to examine a culturally tailored lifestyle intervention in African Americans with type 2 diabetes mellitus and CKD in order to improve clinical, knowledge, self-care, and behavior outcomes in this population.

Citing Articles

Components in downstream health promotions to reduce sugar intake among adults: a systematic review.

Azhar Hilmy S, Nordin N, Mohd Yusof M, Soh T, Yusof N Nutr J. 2024; 23(1):11.

PMID: 38233923 PMC: 10792802. DOI: 10.1186/s12937-023-00884-3.


Combination of Risks of BMI and Health-Related Lifestyles on Kidney Function in the Prediabetic Japanese Population: A Prospective Cohort Study.

Chen J, Deng S, Wagatsuma Y Int J Environ Res Public Health. 2023; 20(7).

PMID: 37047953 PMC: 10094487. DOI: 10.3390/ijerph20075338.

References
1.
Rahman M, Pressel S, Davis B, Nwachuku C, Wright Jr J, Whelton P . Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.... Arch Intern Med. 2005; 165(8):936-46. DOI: 10.1001/archinte.165.8.936. View

2.
Waterman A, Browne T, Waterman B, Gladstone E, Hostetter T . Attitudes and behaviors of African Americans regarding early detection of kidney disease. Am J Kidney Dis. 2008; 51(4):554-62. DOI: 10.1053/j.ajkd.2007.12.020. View

3.
Toobert D, Hampson S, Glasgow R . The summary of diabetes self-care activities measure: results from 7 studies and a revised scale. Diabetes Care. 2000; 23(7):943-50. DOI: 10.2337/diacare.23.7.943. View

4.
Hernandez A, Green J, Janmohamed S, DAgostino Sr R, Granger C, Jones N . Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial. Lancet. 2018; 392(10157):1519-1529. DOI: 10.1016/S0140-6736(18)32261-X. View

5.
Umeukeje E, Wild M, Maripuri S, Davidson T, Rutherford M, Abdel-Kader K . Black Americans' Perspectives of Barriers and Facilitators of Community Screening for Kidney Disease. Clin J Am Soc Nephrol. 2018; 13(4):551-559. PMC: 5969459. DOI: 10.2215/CJN.07580717. View